Acima Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Hold
6,848
0.5% 34
2026
Q1
$1.49M Hold
6,848
0.47% 37
2025
Q4
$1.56M Hold
6,848
0.49% 37
2025
Q3
$1.59M Buy
6,848
+37
+0.5% +$7.54K 0.5% 39
2025
Q2
$1.26M Hold
6,811
0.43% 42
2025
Q1
$1.43M Hold
6,811
0.51% 40
2024
Q4
$1.21M Hold
6,811
0.41% 47
2024
Q3
$1.35M Hold
6,811
0.45% 46
2024
Q2
$1.17M Sell
6,811
-220
-3% -$36.4K 0.43% 45
2024
Q1
$1.28M Hold
7,031
0.47% 48
2023
Q4
$1.09M Sell
7,031
-300
-4% -$43.7K 0.43% 54
2023
Q3
$1.09M Sell
7,331
-165
-2% -$24.2K 0.49% 50
2023
Q2
$1.01M Hold
7,496
0.48% 52
2023
Q1
$1.19M Hold
7,496
0.59% 46
2022
Q4
$1.21M Hold
7,496
0.62% 42
2022
Q3
$1.01M Hold
7,496
0.52% 51
2022
Q2
$1.15M Hold
7,496
0.57% 47
2022
Q1
$1.22M Sell
7,496
-17
-0.2% -$2.47K 0.56% 50
2021
Q4
$1.02M Hold
7,513
0.44% 59
2021
Q3
$810K Hold
7,513
0.37% 62
2021
Q2
$846K Hold
7,513
0.39% 63
2021
Q1
$813K Hold
7,513
0.4% 64
2020
Q4
$805K Buy
7,513
+381
+5% +$36.6K 0.42% 63
2020
Q3
$625K Hold
7,132
0.38% 67
2020
Q2
$700K Buy
7,132
+19
+0.3% +$1.67K 0.45% 61
2020
Q1
$542K Hold
7,113
0.42% 62
2019
Q4
$630K Buy
7,113
+220
+3% +$18.3K 0.44% 60
2019
Q3
$521K Buy
6,893
+165
+2% +$11.3K 0.4% 66
2019
Q2
$489K Hold
6,728
0.39% 64
2019
Q1
$542K Hold
6,728
0.46% 57
2018
Q4
$620K Buy
+6,728
New +$592K 0.61% 40

Other funds holding ABBV

Acima Private Wealth's ABBV Position: Q2 2026 in Review

Acima Private Wealth held its AbbVie (ABBV) position steady in Q2 2026 at 6,848 shares worth $1.72M. The position accounts for 0.5% of the portfolio, ranked #34.

Acima Private Wealth first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Acima Private Wealth held 6,848 shares of AbbVie worth $1.72M as of Q2 2026.
  • Acima Private Wealth left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.5% of Acima Private Wealth's portfolio in Q2 2026, its #34 holding.
  • Acima Private Wealth first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Acima Private Wealth's 13F filing for Q2 2026, filed 6 Jul 2026.